New Zealand Herpes Foundation's Groundbreaking Campaign Wins Prestigious Cannes Lions Grand Prix For Good
The New Zealand Herpes Foundation (NZHF) is proud to announce that its pioneering "Make New Zealand the Best Place in the World to Have Herpes" campaign has been awarded the Lions Health and United Nations Foundation Grand Prix for Good at the 2025 Cannes Lions International Festival of Creativity – one of the most prestigious awards in global advertising and creative excellence.
The campaign, developed in partnership with Motion Sickness (Auckland) and FINCH (Sydney), represents a paradigm shift in public health communications, demonstrating how bold creative strategies can effectively address sensitive health topics and drive measurable behaviour change within healthcare communities and the broader public.
Launched in October 2024 on Global Herpes Awareness Day, the campaign successfully challenged decades of entrenched stigma surrounding genital herpes – a condition that affects up to 80% of New Zealanders at some point in their lives. Through innovative use of humour, gamification, and celebrity endorsement, the initiative transformed a traditionally taboo medical topic into an accessible national conversation.
The campaign's "Herpes Destigmatisation Course" featured prominent New Zealand figures including Sir Ashley Bloomfield and Sir Graham Henry delivering evidence-based health education through engaging video content. A Herpes Stigma Index provided real-time global rankings, encouraging community participation and measuring progress against international benchmarks.
Within eight weeks, New Zealand rose from ninth to first place on the global stigma index. The campaign generated exceptional engagement metrics including:
Over 10,700 hours of educational content consumed
12.7 million impressions across social channels
69% of participants reported reduced stigma attitudes
86% felt more comfortable discussing herpes openly
81% expressed motivation to support others with HSV
The campaign's success underscores the critical importance of addressing the substantial gap between medical reality and public perception of HSV. While most people (~80%) will host a Herpes Simplex Virus during their lifetime, only approximately 20% will experience recognisable symptoms. The majority remain undiagnosed because most people who host herpes simplex don't experience symptoms ( ie are asymptomatic ) creating ongoing challenges for clinical management and patient counselling.
"This campaign demonstrates the transformative power of exceptional creative communications in achieving public health outcomes that traditional medical education approaches have struggled to deliver," said NZHF Trustee Alaina Luxmoore. "We're immensely proud that our bold approach to destigmatising herpes has resonated not only in New Zealand but globally. The message we're conveying is simple – herpes is a common, manageable virus that doesn't define a person's worth or relationships.
"Winning the Cannes Lions Grand Prix for Good validates our belief that innovative communications can break down barriers that have prevented effective clinical care and patient wellbeing for decades. However, this recognition is just the beginning. While we're officially the best place in the world to have herpes, maintaining this title requires constant education, ongoing destigmatisation efforts, and continued advancement in clinical training on best-practice herpes management and treatment guidelines. We're committed to building on this momentum to ensure healthcare providers and patients alike have access to evidence-based, stigma-free herpes care."
The campaign's international acclaim extends beyond Cannes Lions, with awards from AdFest 2025 (Gold Lotus - Entertainment), Clio Health 2025 (multiple Gold and Silver awards), D&AD (Wood Pencils), and The One Show (Bronze - Health & Wellness). This recognition highlights the campaign's effectiveness as a model for addressing sensitive health topics through creative communications.
David Ohana, Chief Communications & Marketing Officer at the United Nations Foundation and Cannes Lions jury president, praised the campaign: "This year's Lions Health Grand Prix for Good unabashedly uses humour to tackle a challenging subject and stigmatisation. Our 2025 awardee took a taboo topic and turned it on its head – showing that with a great strategy, a big, bold crazy idea, and humour for days, that anything is possible."
The campaign's success provides valuable insights for healthcare professionals addressing HSV in clinical practice. By normalising conversations about herpes and emphasising that HSV-1 and HSV-2 are essentially the same virus managed through identical clinical approaches, the initiative supports more effective patient counselling and care delivery.
For healthcare providers, the campaign reinforces that societal conditioning around herpes requires recalibration. HSV-1 causes approximately 50% of genital herpes cases, often through oral-to-genital contact, yet remains socially acceptable when presenting as oral cold sores while carrying significant stigma in genital presentations.
The Foundation's ongoing work will focus on supporting clinical education initiatives, advancing diagnostic understanding, and promoting evidence-based treatment guidelines. With no definitive diagnostic test available for asymptomatic individuals, the campaign's emphasis on reducing stigma becomes even more critical for effective public health management.
The New Zealand Herpes Foundation is dedicated to providing accurate information, support, and advocacy for individuals affected by Herpes Simplex Virus. Through evidence-based education and innovative communications strategies, NZHF works to eliminate stigma and improve health outcomes for all New Zealanders. This includes running a herpes helpline managed by nurse counsellors. The helpline can be reached on 0508 11 12 13 from a landline or 09 433 6526 from a mobile. For more information on the helpline and NZHF's other services visit: herpes.org.nz.
The "Make New Zealand the Best Place in the World to Have Herpes" campaign was supported by Sexually Transmitted Infections Education Foundation, Whānau Ora and Sexual Wellbeing Aotearoa.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
an hour ago
- Scoop
System C Unifies Maternity And Neonatal Care Across New Zealand
System C is proud to announce the continued expansion of the comprehensive BadgerNet Maternity and Neonatal services across New Zealand's hospital districts. This initiative marks a significant step towards unifying maternity and neonatal care in the country. This six-year partnership between System C and Health New Zealand will run until March 2031. The adoption of BadgerNet aligns with both long term goals of New Zealand's Heath Strategy, aiming to achieve health equality and improving the health outcomes for all New Zealanders. System C's maternity and neonatal solutions are built with expectant parents in mind as well as clinicians with the Badger Notes app providing pregnant women with access to their pregnancy notes, empowering them to be involved in their care and promoting a woman-centred approach. Alongside the national adoption of BadgerNet across all hospital districts, System C have also implemented a bespoke Perinatal Spine technology that allows midwifery providers using alternative systems to integrate seamlessly into the national shared care record. Trusted British Tech in New Territories With a strong heritage in the UK as the leading provider of maternity and neonatal solutions across both the NHS and private sector, System C's BadgerNet Neonatal Clinical Summary technology is used in 99.9% of clinical settings in the UK. BadgerNet Neonatal technology ensures that interfacing, charting, clinical care plans and task lists are integrated into one system, supporting clinicians' efficiency their day-to-day activities. System C's BadgerNet Maternity is the only comprehensive solution that enables real-time recording of events and care throughout pregnancy, from pre-conception to postnatal, including early pregnancy and gynaecological care. It offers locally configurable pathways and tasks, eliminating the need for paper records. Guy Lucchi, Managing Director – Healthcare, System C said"We are delighted to bring our cutting-edge maternity and neonatal solutions to New Zealand. This partnership underscores our commitment to enhancing healthcare outcomes through innovative technology. By integrating our BadgerNet systems, we aim to provide seamless, real-time access to critical patient information, empowering clinicians and improving patient care. We look forward to supporting New Zealand's healthcare professionals in delivering the highest standards of care." Aligning with the four priorities for women's health in New Zealand System C is proud to partner with the New Zealand government during this pivotal time, as Aotearoa New Zealand introduces its first Women's Health Strategy. This strategy sets long-term priorities to guide the health system towards equity and healthy futures for women. The four key priorities are: Priority 1: A health system that works for women Priority 2: Improving health care for issues specific to women Priority 3: Better outcomes for mothers, whānau and future generations Priority 4: Living well and ageing well. The need for the investment in maternity services leading to a reduction in overall spend is echoed by a recent study conducted by Science Direct. Utilising real-world data from New Zealand, the only country with fully integrated midwifery continuity-of-care, the study established that midwifery care is cost-saving for public healthcare systems compared to maternity care provided by private obstetricians.' (The impact of caregiver and intended mode of birth on the public cost of care: Cost analysis of maternity and neonatal care in New Zealand - ScienceDirect) This partnership represents a significant milestone in the advancement of maternity and neonatal care in New Zealand. By leveraging System C's innovative technology and expertise, we are committed to supporting healthcare professionals and improving health outcomes for women and their families. Together, we are paving the way for a healthier future, ensuring that every mother and baby receives the highest standard of care.
1News
17 hours ago
- 1News
Medsafe approves sale of melatonin and prescribing magic mushrooms
Relief is on the way for Kiwis struggling with insomnia and treatment-resistant depression, with Medsafe approving the sale of over-the-counter melatonin and the prescription of medicinal psilocybin. Melatonin – used to treat insomnia and jet lag – would be available for purchase in pharmacies without a prescription in due course. The medicine has previously been tightly restricted in New Zealand. Currently, only a handful of melatonin products were approved for people aged over 55. 'Many New Zealanders have asked me why people can buy melatonin overseas but they can't buy it from their local pharmacy. Medsafe has assessed this and decided there's no reason why it shouldn't be available on pharmacy shelves right here at home,' Associate Health Minister David Seymour said. 'In time, adults will be able to buy melatonin directly from a pharmacy with no prescription needed. This is a common sense decision that will make melatonin more accessible in New Zealand than in many other countries and encourage suppliers [to] bring more products to our shelves." ADVERTISEMENT Melatonin would remain prescription-only for children and adolescents, following expert clinical advice to ensure proper oversight when used by younger patients. For the first time in New Zealand, Medsafe has also approved the prescribing of medicinal psilocybin outside of clinical trials, Seymour said. Also known as magic mushrooms, psilocybin was a naturally occurring psychedelic compound found in more than 100 species of mushrooms. While psilocybin would remain as an unapproved medicine, a psychiatrist with prior experience prescribing magic mushrooms in clinical trials has been granted authority to prescribe it to patients with treatment-resistant depression. The prescriptions would be under strict reporting and record-keeping requirements. Seymour said the decision is "huge for people with depression who've tried everything else and are still suffering". "If a doctor believes psilocybin can help, they should have the tools to try." The move brought New Zealand in line with Australia, where "authorised prescribers have been using psilocybin in clinical settings for some time". 'Kiwis shouldn't be left counting sheep or desperate for options when other countries are already using these medicines," Seymour said. "The Government is committed to putting patients first.'
Scoop
17 hours ago
- Scoop
Minister Should Fess Up On Cuts
Simeon Brown needs to be honest about how much more money he expects Health New Zealand to cut from its budget to get back in the black. 'National has chosen to underfund our health system and expects Health New Zealand to make even more cuts - but won't say how much,' Labour health spokesperson Ayesha Verrall said. 'Health New Zealand, which runs our hospitals and other healthcare services, was already $1.1 billion in the red. Funds needed to deal with a growing population and inflation are instead servicing the deficit. 'In today's scrutiny week hearing, Simeon Brown pretended that all the new money from this year's Budget would go on frontline services, but most of it will be swallowed by Health New Zealand's $1.1 billion deficit. 'New Zealanders deserve to know where their money is going. They also deserve timely, quality care both in the community at their local doctor's office, or in hospital should they need it. Simeon Brown is failing on both points. 'Simeon Brown's refusal to answer basic questions—like how much further he's prepared to slash Health New Zealand's budget, or which parts of the health system are on the chopping block—shows a worrying lack of transparency. What is he hiding from New Zealanders? 'National is making cuts to services New Zealanders rely on and is not even brave enough tell us what they are,' Ayesha Verrall said.
